Načítá se...
HDAC4 in ischemic stroke: mechanisms and therapeutic potential
Stroke is one of the leading causes of death and disability worldwide, and the majority of the cases are ischemic stroke. However, it still lacks effective treatment except for thrombolytic therapy in an extremely narrow time window. Increased evidence suggests that histone deacetylase 4 (HDAC4) was...
Uloženo v:
| Vydáno v: | Clin Epigenetics |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136233/ https://ncbi.nlm.nih.gov/pubmed/30208931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0549-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|